ArticleFrontiers in nutrition2026
Strawberry leaf extract protects dopaminergic neurons by restoring redox and mitochondrial homeostasis.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the selective loss of dopaminergic neurons, for which effective disease-modifying strategies remain limited. Mitochondrial dysfunction and oxidative stress are central drivers of PD pathogenesis, highlighting the importance of cellular defense mechanisms targeting these processes. Methods: In the present study, we investigated the neuroprotective effects of strawberry leaf extract (SLE), an agricultural by-product rich in polyphenols, using both in vitro and in vivo models of PD. Results: In SH-SY5Y cells, SLE significantly attenuated rotenone-induced loss of cell viability and suppressed intracellular reactive oxygen species (ROS) production. Mechanistically, SLE promoted nuclear translocation of nuclear factor erythroid 2-related factor 2 (Nrf2) and increased the expression of antioxidant genes, including heme oxygenase-1 (HO-1) and p62. Pharmacological inhibition experiments further indicated that activation of AMP-activated protein kinase (AMPK) contributes to SLE-induced Nrf2 activation. In addition to redox regulation, SLE modulated mitochondrial quality control pathways. Time-dependent alterations in mitophagy-related markers, including PINK1, Parkin, LC3, and p62, were observed, accompanied by recovery of mitochondrial membrane potential. These findings suggest that SLE influences mitochondrial homeostasis under oxidative stress conditions. In a rotenone-induced PD mouse model, SLE administration ameliorated motor dysfunction and attenuated the loss of tyrosine hydroxylase-positive dopaminergic neurons in the substantia nigra. Discussion: Collectively, these results demonstrate that SLE exerts neuroprotective effects through coordinated regulation of the AMPK -Nrf2 signaling axis and mitochondrial quality control pathways. This study provides mechanistic insight into the potential of food-derived bioactive compounds as modulators of neurodegenerative processes and highlights SLE as a promising candidate for PD prevention or intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.